The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nivolumab Injection Market Research Report 2024
Synopsis
Nivolumab Injection is suitable for treating adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who are negative for mutations in the epidermal growth factor receptor (EGFR) gene and negative for anaplastic lymphoma kinase (ALK), who have previously undergone platinum-containing chemotherapy and whose disease has progressed or is intolerable.
The global Nivolumab Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Nivolumab Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nivolumab Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Nivolumab Injection include AbbVie, Allergan, Ono Pharmaceutical, Sinopharm and Bristol-Myers Squibb, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nivolumab Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nivolumab Injection.
Report Scope
The Nivolumab Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nivolumab Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nivolumab Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Allergan
Ono Pharmaceutical
Sinopharm
Bristol-Myers Squibb
Segment by Type
100IU
50IU
Other
Segment by Application
Unresectable Melanoma
Metastatic Melanoma
Metastatic Squamous NSCLC
Classical Hodgkin Lymphoma
Renal Cell Carcinoma
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nivolumab Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nivolumab Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Nivolumab Injection is suitable for treating adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who are negative for mutations in the epidermal growth factor receptor (EGFR) gene and negative for anaplastic lymphoma kinase (ALK), who have previously undergone platinum-containing chemotherapy and whose disease has progressed or is intolerable.
The global Nivolumab Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Nivolumab Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nivolumab Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Nivolumab Injection include AbbVie, Allergan, Ono Pharmaceutical, Sinopharm and Bristol-Myers Squibb, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nivolumab Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nivolumab Injection.
Report Scope
The Nivolumab Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nivolumab Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nivolumab Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Allergan
Ono Pharmaceutical
Sinopharm
Bristol-Myers Squibb
Segment by Type
100IU
50IU
Other
Segment by Application
Unresectable Melanoma
Metastatic Melanoma
Metastatic Squamous NSCLC
Classical Hodgkin Lymphoma
Renal Cell Carcinoma
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nivolumab Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nivolumab Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Nivolumab Injection Market Overview
1.1 Product Overview and Scope of Nivolumab Injection
1.2 Nivolumab Injection Segment by Type
1.2.1 Global Nivolumab Injection Market Value Comparison by Type (2024-2030)
1.2.2 100IU
1.2.3 50IU
1.2.4 Other
1.3 Nivolumab Injection Segment by Application
1.3.1 Global Nivolumab Injection Market Value by Application: (2024-2030)
1.3.2 Unresectable Melanoma
1.3.3 Metastatic Melanoma
1.3.4 Metastatic Squamous NSCLC
1.3.5 Classical Hodgkin Lymphoma
1.3.6 Renal Cell Carcinoma
1.3.7 Other
1.4 Global Nivolumab Injection Market Size Estimates and Forecasts
1.4.1 Global Nivolumab Injection Revenue 2019-2030
1.4.2 Global Nivolumab Injection Sales 2019-2030
1.4.3 Global Nivolumab Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Nivolumab Injection Market Competition by Manufacturers
2.1 Global Nivolumab Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Nivolumab Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Nivolumab Injection Average Price by Manufacturers (2019-2024)
2.4 Global Nivolumab Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nivolumab Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nivolumab Injection, Product Type & Application
2.7 Nivolumab Injection Market Competitive Situation and Trends
2.7.1 Nivolumab Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nivolumab Injection Players Market Share by Revenue
2.7.3 Global Nivolumab Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nivolumab Injection Retrospective Market Scenario by Region
3.1 Global Nivolumab Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Nivolumab Injection Global Nivolumab Injection Sales by Region: 2019-2030
3.2.1 Global Nivolumab Injection Sales by Region: 2019-2024
3.2.2 Global Nivolumab Injection Sales by Region: 2025-2030
3.3 Global Nivolumab Injection Global Nivolumab Injection Revenue by Region: 2019-2030
3.3.1 Global Nivolumab Injection Revenue by Region: 2019-2024
3.3.2 Global Nivolumab Injection Revenue by Region: 2025-2030
3.4 North America Nivolumab Injection Market Facts & Figures by Country
3.4.1 North America Nivolumab Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Nivolumab Injection Sales by Country (2019-2030)
3.4.3 North America Nivolumab Injection Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nivolumab Injection Market Facts & Figures by Country
3.5.1 Europe Nivolumab Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Nivolumab Injection Sales by Country (2019-2030)
3.5.3 Europe Nivolumab Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nivolumab Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Nivolumab Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Nivolumab Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Nivolumab Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Nivolumab Injection Market Facts & Figures by Country
3.7.1 Latin America Nivolumab Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Nivolumab Injection Sales by Country (2019-2030)
3.7.3 Latin America Nivolumab Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nivolumab Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Nivolumab Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Nivolumab Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Nivolumab Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nivolumab Injection Sales by Type (2019-2030)
4.1.1 Global Nivolumab Injection Sales by Type (2019-2024)
4.1.2 Global Nivolumab Injection Sales by Type (2025-2030)
4.1.3 Global Nivolumab Injection Sales Market Share by Type (2019-2030)
4.2 Global Nivolumab Injection Revenue by Type (2019-2030)
4.2.1 Global Nivolumab Injection Revenue by Type (2019-2024)
4.2.2 Global Nivolumab Injection Revenue by Type (2025-2030)
4.2.3 Global Nivolumab Injection Revenue Market Share by Type (2019-2030)
4.3 Global Nivolumab Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Nivolumab Injection Sales by Application (2019-2030)
5.1.1 Global Nivolumab Injection Sales by Application (2019-2024)
5.1.2 Global Nivolumab Injection Sales by Application (2025-2030)
5.1.3 Global Nivolumab Injection Sales Market Share by Application (2019-2030)
5.2 Global Nivolumab Injection Revenue by Application (2019-2030)
5.2.1 Global Nivolumab Injection Revenue by Application (2019-2024)
5.2.2 Global Nivolumab Injection Revenue by Application (2025-2030)
5.2.3 Global Nivolumab Injection Revenue Market Share by Application (2019-2030)
5.3 Global Nivolumab Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Nivolumab Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AbbVie Nivolumab Injection Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Allergan
6.2.1 Allergan Corporation Information
6.2.2 Allergan Description and Business Overview
6.2.3 Allergan Nivolumab Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Allergan Nivolumab Injection Product Portfolio
6.2.5 Allergan Recent Developments/Updates
6.3 Ono Pharmaceutical
6.3.1 Ono Pharmaceutical Corporation Information
6.3.2 Ono Pharmaceutical Description and Business Overview
6.3.3 Ono Pharmaceutical Nivolumab Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Ono Pharmaceutical Nivolumab Injection Product Portfolio
6.3.5 Ono Pharmaceutical Recent Developments/Updates
6.4 Sinopharm
6.4.1 Sinopharm Corporation Information
6.4.2 Sinopharm Description and Business Overview
6.4.3 Sinopharm Nivolumab Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sinopharm Nivolumab Injection Product Portfolio
6.4.5 Sinopharm Recent Developments/Updates
6.5 Bristol-Myers Squibb
6.5.1 Bristol-Myers Squibb Corporation Information
6.5.2 Bristol-Myers Squibb Description and Business Overview
6.5.3 Bristol-Myers Squibb Nivolumab Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bristol-Myers Squibb Nivolumab Injection Product Portfolio
6.5.5 Bristol-Myers Squibb Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nivolumab Injection Industry Chain Analysis
7.2 Nivolumab Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nivolumab Injection Production Mode & Process
7.4 Nivolumab Injection Sales and Marketing
7.4.1 Nivolumab Injection Sales Channels
7.4.2 Nivolumab Injection Distributors
7.5 Nivolumab Injection Customers
8 Nivolumab Injection Market Dynamics
8.1 Nivolumab Injection Industry Trends
8.2 Nivolumab Injection Market Drivers
8.3 Nivolumab Injection Market Challenges
8.4 Nivolumab Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Nivolumab Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Nivolumab Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Nivolumab Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Nivolumab Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Nivolumab Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Nivolumab Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Nivolumab Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Nivolumab Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Nivolumab Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Nivolumab Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nivolumab Injection, Product Type & Application
Table 12. Global Key Manufacturers of Nivolumab Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nivolumab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nivolumab Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nivolumab Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Nivolumab Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Nivolumab Injection Sales Market Share by Region (2019-2024)
Table 19. Global Nivolumab Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Nivolumab Injection Sales Market Share by Region (2025-2030)
Table 21. Global Nivolumab Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Nivolumab Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Nivolumab Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Nivolumab Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Nivolumab Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Nivolumab Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Nivolumab Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Nivolumab Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Nivolumab Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Nivolumab Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Nivolumab Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Nivolumab Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Nivolumab Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Nivolumab Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Nivolumab Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Nivolumab Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Nivolumab Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Nivolumab Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Nivolumab Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Nivolumab Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Nivolumab Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Nivolumab Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Nivolumab Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Nivolumab Injection Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Nivolumab Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Nivolumab Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Nivolumab Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Nivolumab Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Nivolumab Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Nivolumab Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Nivolumab Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Nivolumab Injection Sales Market Share by Type (2019-2024)
Table 53. Global Nivolumab Injection Sales Market Share by Type (2025-2030)
Table 54. Global Nivolumab Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Nivolumab Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Nivolumab Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Nivolumab Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Nivolumab Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Nivolumab Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Nivolumab Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Nivolumab Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Nivolumab Injection Sales Market Share by Application (2019-2024)
Table 63. Global Nivolumab Injection Sales Market Share by Application (2025-2030)
Table 64. Global Nivolumab Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Nivolumab Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Nivolumab Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Nivolumab Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Nivolumab Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Nivolumab Injection Price (US$/Unit) by Application (2025-2030)
Table 70. AbbVie Corporation Information
Table 71. AbbVie Description and Business Overview
Table 72. AbbVie Nivolumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. AbbVie Nivolumab Injection Product
Table 74. AbbVie Recent Developments/Updates
Table 75. Allergan Corporation Information
Table 76. Allergan Description and Business Overview
Table 77. Allergan Nivolumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Allergan Nivolumab Injection Product
Table 79. Allergan Recent Developments/Updates
Table 80. Ono Pharmaceutical Corporation Information
Table 81. Ono Pharmaceutical Description and Business Overview
Table 82. Ono Pharmaceutical Nivolumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Ono Pharmaceutical Nivolumab Injection Product
Table 84. Ono Pharmaceutical Recent Developments/Updates
Table 85. Sinopharm Corporation Information
Table 86. Sinopharm Description and Business Overview
Table 87. Sinopharm Nivolumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Sinopharm Nivolumab Injection Product
Table 89. Sinopharm Recent Developments/Updates
Table 90. Bristol-Myers Squibb Corporation Information
Table 91. Bristol-Myers Squibb Description and Business Overview
Table 92. Bristol-Myers Squibb Nivolumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Bristol-Myers Squibb Nivolumab Injection Product
Table 94. Bristol-Myers Squibb Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Nivolumab Injection Distributors List
Table 98. Nivolumab Injection Customers List
Table 99. Nivolumab Injection Market Trends
Table 100. Nivolumab Injection Market Drivers
Table 101. Nivolumab Injection Market Challenges
Table 102. Nivolumab Injection Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nivolumab Injection
Figure 2. Global Nivolumab Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Nivolumab Injection Market Share by Type in 2023 & 2030
Figure 4. 100IU Product Picture
Figure 5. 50IU Product Picture
Figure 6. Other Product Picture
Figure 7. Global Nivolumab Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Nivolumab Injection Market Share by Application in 2023 & 2030
Figure 9. Unresectable Melanoma
Figure 10. Metastatic Melanoma
Figure 11. Metastatic Squamous NSCLC
Figure 12. Classical Hodgkin Lymphoma
Figure 13. Renal Cell Carcinoma
Figure 14. Other
Figure 15. Global Nivolumab Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Nivolumab Injection Market Size (2019-2030) & (US$ Million)
Figure 17. Global Nivolumab Injection Sales (2019-2030) & (K Units)
Figure 18. Global Nivolumab Injection Average Price (US$/Unit) & (2019-2030)
Figure 19. Nivolumab Injection Report Years Considered
Figure 20. Nivolumab Injection Sales Share by Manufacturers in 2023
Figure 21. Global Nivolumab Injection Revenue Share by Manufacturers in 2023
Figure 22. The Global 5 and 10 Largest Nivolumab Injection Players: Market Share by Revenue in 2023
Figure 23. Nivolumab Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 24. Global Nivolumab Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Nivolumab Injection Sales Market Share by Country (2019-2030)
Figure 26. North America Nivolumab Injection Revenue Market Share by Country (2019-2030)
Figure 27. U.S. Nivolumab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Nivolumab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Nivolumab Injection Sales Market Share by Country (2019-2030)
Figure 30. Europe Nivolumab Injection Revenue Market Share by Country (2019-2030)
Figure 31. Germany Nivolumab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Nivolumab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Nivolumab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Nivolumab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia Nivolumab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Nivolumab Injection Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Nivolumab Injection Revenue Market Share by Region (2019-2030)
Figure 38. China Nivolumab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Nivolumab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Nivolumab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Nivolumab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Nivolumab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Taiwan Nivolumab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Indonesia Nivolumab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Thailand Nivolumab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Malaysia Nivolumab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Philippines Nivolumab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Latin America Nivolumab Injection Sales Market Share by Country (2019-2030)
Figure 49. Latin America Nivolumab Injection Revenue Market Share by Country (2019-2030)
Figure 50. Mexico Nivolumab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Brazil Nivolumab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Argentina Nivolumab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Middle East & Africa Nivolumab Injection Sales Market Share by Country (2019-2030)
Figure 54. Middle East & Africa Nivolumab Injection Revenue Market Share by Country (2019-2030)
Figure 55. Turkey Nivolumab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Saudi Arabia Nivolumab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. UAE Nivolumab Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. Global Sales Market Share of Nivolumab Injection by Type (2019-2030)
Figure 59. Global Revenue Market Share of Nivolumab Injection by Type (2019-2030)
Figure 60. Global Nivolumab Injection Price (US$/Unit) by Type (2019-2030)
Figure 61. Global Sales Market Share of Nivolumab Injection by Application (2019-2030)
Figure 62. Global Revenue Market Share of Nivolumab Injection by Application (2019-2030)
Figure 63. Global Nivolumab Injection Price (US$/Unit) by Application (2019-2030)
Figure 64. Nivolumab Injection Value Chain
Figure 65. Nivolumab Injection Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
